As you may recall, on February 28, 2023, the Drug Enforcement Agency (DEA) proposed new rules, Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior In-Person Medical Evaluation, which eliminate the pandemic-era flexibilities for prescribing controlled substances via telehealth.
The DEA received more than 38,000 comments on its proposed rules. In order to consider all the comments, DEA announced today, May 9, 2023, it is extending its pandemic-era telehealth flexibilities through November 11, 2023.
We are continuing to monitor the progress of this DEA proposal and will share updates with you as they come in.
If you have any questions, please email Chris Crosser at gro.n1686155167ppaa@1686155167sirhc1686155167.